{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:33:10Z","timestamp":1786116790931,"version":"build-2736575974"},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Perinatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clp.2026.04.005","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:43:05Z","timestamp":1780519385000},"page":"551-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Viral Infections During Pregnancy"],"prefix":"10.1016","volume":"53","author":[{"given":"Angela M.","family":"Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errol R.","family":"Norwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clp.2026.04.005_bib1","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra1213566","article-title":"Pregnancy and infection","volume":"370","author":"Kourtis","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.005_bib2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1172\/JCI87490","article-title":"Risks associated with viral infections during pregnancy","volume":"127","author":"Racicot","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.clp.2026.04.005_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41390-024-03145-z","article-title":"Viral infections in pregnancy and impact on offspring neurodevelopment: mechanisms and lessons learned","volume":"96","author":"Yates","year":"2024","journal-title":"Pediatr Res"},{"key":"10.1016\/j.clp.2026.04.005_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2024-056307","article-title":"Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses","volume":"101","author":"Harfouche","year":"2025","journal-title":"Sex Transm Infect"},{"issue":"43","key":"10.1016\/j.clp.2026.04.005_bib5","first-page":"e1","article-title":"Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States","volume":"196","author":"Xu","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib6","series-title":"Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14-49: united States, 2015-2016. NCHS Data Brief No. 304. Hyattsville (MD)","author":"Mcquillan","year":"2018"},{"key":"10.1016\/j.clp.2026.04.005_bib7","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/cid\/ciy318","article-title":"Seroprevalence of herpes simplex virus types 1 and 2 among pregnant women and sexually active, nonpregnant women in the United States","volume":"67","author":"Patton","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jama.2023.0057","article-title":"Serologic screening for genital herpes infection: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement","volume":"329","author":"Mangione","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.04.005_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/cid\/cis891","article-title":"Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women","volume":"56","author":"Bernstein","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199708213370801","article-title":"The acquisition of herpes simplex virus during pregnancy","volume":"337","author":"Brown","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.005_bib11","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/AOG.0000000000003840","article-title":"ACOG Practice Bulletin no. 220. Management of genital herpes in pregnancy","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib12","series-title":"Sexually transmitted infections treatment guidelines, 2021","year":"2021"},{"key":"10.1016\/j.clp.2026.04.005_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.clp.2026.04.005_bib14","article-title":"Acetaminophen use in pregnancy and neurodevelopmental outcomes","year":"2025","journal-title":"ACOG Practice Advisory"},{"key":"10.1016\/j.clp.2026.04.005_bib16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jama.2024.3172","article-title":"Acetaminophen use during pregnancy and children\u2019s risk of autism, ADHD, and intellectual disability","volume":"331","author":"Ahlqvist","year":"2024","journal-title":"JAMA"},{"issue":"64","key":"10.1016\/j.clp.2026.04.005_bib17","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0002-9378(11)80023-2","article-title":"Pharmacokinetics of acyclovir in the term human pregnancy and neonate","volume":"1","author":"Frenkel","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib18","first-page":"102","article-title":"Oral acyclovir and recurrent genital herpes during late pregnancy","volume":"82","author":"Haddad","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0002-9378(98)70176-0","article-title":"Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy","volume":"179","author":"Kimberlin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/jama.2010.1206","article-title":"Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects","volume":"304","author":"Pasternak","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.04.005_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/bdra.20013","article-title":"Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999","volume":"70","author":"Stone","year":"2004","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.clp.2026.04.005_bib22","first-page":"427","article-title":"Safety of antiviral medication for the treatment of herpes during pregnancy","volume":"57","author":"Kang","year":"2011","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.clp.2026.04.005_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.reprotox.2004.11.014","article-title":"Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection","volume":"21","author":"Avgil","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.clp.2026.04.005_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/pd.5587","article-title":"Fetal and neonatal abnormalities due to congenital herpes simplex virus infection: a literature review","volume":"40","author":"Fa","year":"2020","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.clp.2026.04.005_bib25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/siny.2002.0115","article-title":"Neonatal herpes infection: diagnosis, treatment and prevention","author":"Enright","year":"2002","journal-title":"Semin Neonatol"},{"key":"10.1016\/j.clp.2026.04.005_bib26","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM199105023241804","article-title":"Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor","volume":"324","author":"Brown","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.005_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/385697","article-title":"Herpes simplex virus infection in pregnancy","volume":"2012","author":"Straface","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant","volume":"289","author":"Brown","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clp.2026.04.005_bib29","first-page":"1396","article-title":"Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review","volume":"102","author":"Sheffield","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib30","first-page":"CD004946","article-title":"Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection","volume":"1","author":"Hollier","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clp.2026.04.005_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12978-017-0292-7","article-title":"Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial","volume":"14","author":"Nakubulwa","year":"2017","journal-title":"Reprod Health"},{"key":"10.1016\/j.clp.2026.04.005_bib32","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mob.2003.185","article-title":"A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery","volume":"188","author":"Watts","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpeds.2011.12.053","article-title":"Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series","volume":"161","author":"Pinninti","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2026.04.005_bib34","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/v17040538","article-title":"Efficacy and safety of antivirals in lactating women with herpesviridae infections: a systematic review","volume":"17","author":"Kallia","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.clp.2026.04.005_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2002.119183","article-title":"Acyclovir concentrations in human breast milk after valaciclovir administration","volume":"186","author":"Sheffield","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02163-19","article-title":"Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity","volume":"94","author":"Patel","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.clp.2026.04.005_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103581","article-title":"Bidirectional transfer of pritelivir across term human placenta and its effect on placental functions","volume":"392","author":"Bryant","year":"2025","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.clp.2026.04.005_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.959603","article-title":"Monoclonal antibody therapy of herpes simplex virus: an opportunity to decrease congenital and perinatal infections","volume":"13","author":"Backes","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.clp.2026.04.005_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12929-024-01045-2","article-title":"Development of a highly effective combination monoclonal antibody therapy against herpes simplex virus","volume":"31","author":"Seyfizadeh","year":"2024","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.clp.2026.04.005_bib41","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/rmv.659","article-title":"Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV","volume":"20","author":"Hyde","year":"2010","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.clp.2026.04.005_bib43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ajog.2020.02.018","article-title":"Cytomegalovirus infection during pregnancy: state of the science","volume":"223","author":"Leruez-Ville","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib44","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/jcm13020640","article-title":"Cytomegalovirus and pregnancy: a narrative review","volume":"13","author":"Pontes","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.clp.2026.04.005_bib45","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1097\/01.AOG.0000466430.19823.53","article-title":"ACOG Practice Bulletin No. 151: cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5468\/ogs.23117","article-title":"Cytomegalovirus infection during pregnancy","volume":"66","author":"Choodinatha","year":"2023","journal-title":"Obstet Gynecol Sci"},{"key":"10.1016\/j.clp.2026.04.005_bib47","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3390\/diagnostics13142397","article-title":"Ultrasonographic signs of cytomegalovirus infection in the fetus: a systematic review of the literature","volume":"13","author":"Rybak-Krzyszkowska","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.clp.2026.04.005_bib48","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/AOG.0000000000005840","article-title":"Evaluation and management of congenital cytomegalovirus infection","volume":"145","author":"Coskun","year":"2025","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib49","doi-asserted-by":"crossref","first-page":"380.e1","DOI":"10.1016\/j.ajog.2007.09.052","article-title":"Ultrasound prediction of symptomatic congenital cytomegalovirus infection","volume":"198","author":"Guerra","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/pd.4340","article-title":"Detailed in utero ultrasound description of 30 cases of congenital cytomegalovirus infection","volume":"34","author":"Picone","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.clp.2026.04.005_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100641","article-title":"Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network. Amniocentesis to diagnose congenital cytomegalovirus infection following maternal primary infection","volume":"4","author":"Dinsmoor","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.clp.2026.04.005_bib52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.reprotox.2005.02.002","article-title":"Fetal effects of primary and secondary cytomegalovirus infection in pregnancy","volume":"21","author":"Ornoy","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.clp.2026.04.005_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/rmv.535","article-title":"Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.clp.2026.04.005_bib54","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib55","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00431-002-1115-5","article-title":"Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature","volume":"162","author":"Gaytant","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.clp.2026.04.005_bib56","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/pd.4118","article-title":"A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome","volume":"33","author":"Picone","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.clp.2026.04.005_bib57","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ajog.2020.05.038","article-title":"Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences","volume":"223","author":"Chatzakis","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib58","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcv.2011.07.005","article-title":"Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age","volume":"52","author":"Enders","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clp.2026.04.005_bib59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.clp.2026.04.005_bib60","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/600882","article-title":"Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population","volume":"49","author":"Mussi-Pinhata","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib61","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM198511143132006","article-title":"Herpesvirus infections of pregnancy","volume":"313","author":"Stagno","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.005_bib62","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3476(97)70248-8","article-title":"Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection","volume":"130","author":"Fowler","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.clp.2026.04.005_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/peds.104.1.55","article-title":"Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus","volume":"104","author":"Boppana","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.clp.2026.04.005_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2007.09.004","article-title":"Congenital cytomegalovirus infection as a cause of permanent bilateral hearing loss: a quantitative assessment","volume":"41","author":"Grosse","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.clp.2026.04.005_bib65","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3928\/01913913-20220426-01","article-title":"Congenital cytomegalovirus infection and ophthalmological disorders: a systematic review","volume":"60","author":"Gabrani","year":"2023","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.clp.2026.04.005_bib66","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.005_bib67","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJMoa043337","article-title":"Passive immunization during pregnancy for congenital cytomegalovirus infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.005_bib68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cid\/cis423","article-title":"Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age","volume":"55","author":"Visentin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/infdis\/jir718","article-title":"Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy\u2013a case-control study of the outcome in children","volume":"205","author":"Nigro","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib70","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jogc.2018.03.013","article-title":"Use of cytomegalovirus-specific hyperimmunoglobulins in pregnancy: a retrospective cohort","volume":"40","author":"Minsart","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.clp.2026.04.005_bib71","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14767058.2017.1387890","article-title":"Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid","volume":"32","author":"Bl\u00e1zquez-Gamero","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.clp.2026.04.005_bib72","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.005_bib73","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1913569","article-title":"Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. A trial of hyperimmune globulin to prevent congenital cytomegalovirus infection","volume":"385","author":"Hughes","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clp.2026.04.005_bib74","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2016.02.042","article-title":"Diagnosis and antenatal management of congenital cytomegalovirus infection","volume":"214","author":"Hughes","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib75","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/S1473-3099(17)30143-3","article-title":"International Congenital Cytomegalovirus Recommendations Group. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy","volume":"17","author":"Rawlinson","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib76","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-0528.2007.01308.x","article-title":"Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection","volume":"114","author":"Jacquemard","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.clp.2026.04.005_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib78","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clp.2026.04.005_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ajog.2023.07.022","article-title":"The effect of valacyclovir on secondary prevention of congenital cytomegalovirus infection, following primary maternal infection acquired periconceptionally or in the first trimester of pregnancy. An individual patient data meta-analysis","volume":"230","author":"Chatzakis","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clp.2026.04.005_bib80","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jogoh.2019.01.003","article-title":"Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection","volume":"48","author":"Codaccioni","year":"2019","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.clp.2026.04.005_bib81","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/cid\/ciad230","article-title":"Revised protocol for secondary prevention of congenital cytomegalovirus infection with valaciclovir following infection in early pregnancy","volume":"77","author":"Amir","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clp.2026.04.005_bib82","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jmwh.13228","article-title":"Cytomegalovirus infection in pregnancy: prevention, presentation, management and neonatal outcomes","volume":"66","author":"Pesch","year":"2021","journal-title":"J Midwifery Womens Health"},{"key":"10.1016\/j.clp.2026.04.005_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01627-20","article-title":"Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy","volume":"65","author":"Hamilton","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clp.2026.04.005_bib84","author":"Kroger"},{"key":"10.1016\/j.clp.2026.04.005_bib85","first-page":"555","article-title":"Vaccination during pregnancy","volume":"57","author":"Bozzo","year":"2011","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.clp.2026.04.005_bib86","first-page":"1117","article-title":"Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine","volume":"50","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clp.2026.04.005_bib87","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"}],"container-title":["Clinics in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095510826000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:15:23Z","timestamp":1786018523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095510826000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0095510826000345"],"URL":"https:\/\/doi.org\/10.1016\/j.clp.2026.04.005","relation":{},"ISSN":["0095-5108"],"issn-type":[{"value":"0095-5108","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Viral Infections During Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clp.2026.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}